Patent holdings for IPC class G01N 30/50

Total number of patents in this class: 110

10-year publication summary

5
9
7
8
6
11
6
3
12
1
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Shimadzu Corporation
6306
6
Regeneron Pharmaceuticals, Inc.
4608
6
Waters Technologies Corporation
1778
6
GE Healthcare Bio-Sciences AB
520
4
Cytiva Sweden AB
782
4
Bristol-myers Squibb Company
4812
3
JSR Corporation
2513
3
Bio-Rad Laboratories, Inc.
1613
3
Quest Diagnostics Investments LLC
425
3
Repligen Corporation
293
3
Biotage AB
93
2
Genzyme Corporation
1338
2
Global Life Sciences Solutions USA LLC
525
2
Cytiva BioProcess R&D AB
322
2
F. Hoffmann-La Roche AG
7839
1
Hoffmann-La Roche Inc.
3696
1
ExxonMobil Research And Engineering Company
2468
1
EMD Millipore Corporation
633
1
Merck Patent GmbH
5663
1
Centre National de La Recherche Scientifique
10881
1
Other owners 55